EARLY PLACENTA INSULIN-LIKE PEPTIDE (PRO-EPIL)

摘要

The present invention relates to a method for the diagnosis, prognosis, risk assessment, risk stratification and/or therapy control of a prenatal disorder or condition in a pregnant female subject or the unborn fetus of said subject comprising the steps of: i) providing a sample of a bodily fluid of said subject; ii) determining the level of early placenta insulin-like peptide (pro-EPIL) or a fragment thereof in said sample; iii) comparing the determined level in the sample to a control level derived from subjects without said prenatal disorder or condition; wherein a deviation from said control level is indicative for said prenatal disorder or condition in said subject.